Leading Healthcare Engagement Technology Platform Brings in Proven Leadership to Drive Customer Focus and Continued Innovation
Indianapolis, IN: August 29, 2018 — Healthx, Inc., the leading healthcare technology engagement platform announces the appointment of healthcare technology industry veteran Gene Cattarina as new CEO and Mark Rapoport as CFO.
Prior to joining Healthx, Cattarina established an impressive track record of success, leading numerous healthcare technology companies through major growth in business sectors including healthcare information systems, software, products, devices, and professional services. Most recently he was CEO of SafeOp Surgical, Inc. (now an Alphatec company) the developer and provider of the EPAD™ System, a unique, simple-to-use, and cost-effective neurological monitoring solution. Previous to SafeOp, he was President and CEO of Capsule Technologies (now a part of Qualcomm Life) the industry leading provider of medical device integration solutions. Gene has also held CEO and President positions at Lynx Medical Systems; Landacorp, Inc.; Medicode; and TDS Healthcare Systems, now part of Allscripts.
“The things happening at Healthx are very exciting and I am honored to have the privilege of leading the company through this next phase of innovation and growth,” said Cattarina. “I’m thrilled to join the vibrant tech scene here in Indianapolis with the likes of Salesforce, Lessonly, Sigstr, and others. Healthx has an incredible history of technological innovation in healthcare. Most recently, Healthx has focused on its platform technology that orchestrates the complex healthcare journey, initiating interactions between health plans and TPAs, providers, and members.”
Joining Cattarina is Mark Rapoport as Chief Financial Officer. Rapoport also has a rich history of leadership in healthcare technology, holding CFO positions at Visioneering Technologies, Inc. (VTI) and Capsule Technologie SAS, as well as President & CEO of Thomas, Thomas & Walsh, Inc., and COO and CFO of Landacorp, Inc.
Seth T. Godwin